Isolation of T cell populations with specific TCRs from the human body, massive expansion by T cell growth factor (IL-2) in vitro and finally reinfusion into patients to achieve cancer elimination are many ways for ACT application (Met et al., 2019). The gene discussed is IL2; the disease is cancer.